Primary Aldosteronism and Risk of Cardiovascular Outcomes: Genome-Wide Association and Mendelian Randomization Study

Kosuke Inoue1,2, Tatsuhiko Naito3,4, Ryosuke Fuji5,6

  • 1Department of Social Epidemiology, Graduate School of Medicine Kyoto University Kyoto Japan.

Insights

Primary aldosteronism (PA) causally increases the risk of coronary artery disease (CAD), congestive heart failure (CHF), and stroke. Early screening for PA is vital for preventing cardiovascular events.

Area of Science:

  • Cardiovascular Genetics
  • Endocrinology
  • Epidemiology

Background:

  • Observational studies suggest a link between primary aldosteronism (PA) and adverse cardiovascular outcomes like coronary artery disease (CAD), congestive heart failure (CHF), and stroke.
  • Establishing a causal relationship is hindered by a lack of randomized controlled trial data.
  • This study investigates the causal role of PA in the development of CAD, CHF, and stroke.

Purpose of the Study:

  • To determine the causal relationship between primary aldosteronism (PA) and the risk of incident coronary artery disease (CAD), congestive heart failure (CHF), and stroke.
  • To leverage genetic variants associated with PA as instrumental variables in a Mendelian randomization analysis.
  • To provide evidence supporting early screening and intervention for PA to mitigate cardiovascular risks.

Main Methods:

  • A cross-ancestry meta-analysis of genome-wide association studies (GWAS) was performed to identify single-nucleotide variants (SNVs) associated with PA.
  • Seven genetic loci significantly associated with PA risk were identified, including genes near CASZ1, WNT2B, HOTTIP, LSP1, TBX3, RXFP2, and NDP.
  • A 2-sample Mendelian randomization analysis was conducted using these genetic variants as instrumental variables to assess the causal effect of PA on incident CAD, CHF, and stroke in East Asian and European populations.

Main Results:

  • The cross-ancestry GWAS meta-analysis identified 7 genetic loci robustly associated with PA risk.
  • Mendelian randomization analysis indicated that PA causally increases the risk of CAD (OR 1.07, 95% CI 1.03-1.11), CHF (OR 1.10, 95% CI 1.01-1.20), and stroke (OR 1.13, 95% CI 1.09-1.18) in the East Asian population.
  • These causal associations were consistent across both East Asian and European ancestry populations.

Conclusions:

  • Primary aldosteronism (PA) is causally associated with an increased risk of developing coronary artery disease (CAD), congestive heart failure (CHF), and stroke.
  • These findings underscore the critical importance of early and proactive screening for PA.
  • Timely identification and management of PA can potentially prevent future cardiovascular events.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
406
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.0K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
381
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.0K
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.4K